Tissue Transglutaminase-Catalyzed Formation of High-Molecular-Weight Aggregatesin VitroIs Favored with Long Polyglutamine Domains: A Possible Mechanism Contributing to CAG-Triplet Diseases (original) (raw)

Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease

Sharon Groover

Biochemistry, 2017

View PDFchevron_right

Transglutaminase Activity Is Involved in Polyamine-Induced Programmed Cell Death

Simone Beninati

Experimental Cell Research, 2001

View PDFchevron_right

Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and α-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length

Osamu Onodera

Proceedings of the National Academy of Sciences, 1997

View PDFchevron_right

Polyglutamine disease: from pathogenesis to therapy

Jacquie Greenberg

South African Medical Journal, 2012

View PDFchevron_right

Cellular Toxicity of Polyglutamine Expansion Proteins

Manajit Hayer-Hartl

Molecular Cell, 2004

View PDFchevron_right

Transglutaminases and neurodegeneration

Boris Krasnikov

Journal of Neurochemistry, 2009

View PDFchevron_right

Polyglutamine diseases: where does toxicity come from? what is toxicity? where are we going?

Osamu Onodera

Journal of molecular cell biology, 2010

View PDFchevron_right

Pathogenesis of polyglutamine disorders: aggregation revisited

Christine Van Broeckhoven

Human Molecular Genetics, 2003

View PDFchevron_right

Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)n/Qn-expansion diseases?

Vittorio Gentile

Neurochemistry International, 2002

View PDFchevron_right

Polyglutamine fibrillogenesis: The pathway unfolds

Michelle Poirier

Proceedings of the National Academy of Sciences, 2002

View PDFchevron_right

Polyglutamine Domains Are Substrates of Tissue Transglutaminase: Does Transglutaminase Play a Role in Expanded CAG/Poly-Q Neurodegenerative Diseases?

Osamu Onodera

Journal of Neurochemistry, 2002

View PDFchevron_right

Early increases in transglutaminase activity and polyamine levels in a Mallory-Denk body mouse model

Adriana Cochón

Toxicology Letters, 2010

View PDFchevron_right

Molecular origin of polyglutamine aggregation in neurodegenerative diseases

Nikolay Dokholyan

PLoS Computational Biology, 2005

View PDFchevron_right

Polyglutamine-Mediated Aggregation and Cell Death

Enrico V. Avvedimento

Biochemical and Biophysical Research Communications, 2000

View PDFchevron_right

Post-translational modifications of expanded polyglutamine proteins: impact on neurotoxicity

Maria Pennuto

Human Molecular Genetics, 2009

View PDFchevron_right

Differences in transglutaminase mRNA after polyamine depletion in two cell lines

Leonard Johnson

American Journal of Physiology-Cell Physiology, 1998

View PDFchevron_right

Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: Relevance to diseases of the nervous system

Pascal Kahlem

Proceedings of the National Academy of Sciences, 1996

View PDFchevron_right

Properties of polyglutamine expansion in vitro and in a cellular model for Huntington's disease

Denis Moras

Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 1999

View PDFchevron_right

Pharmacological protein targets in polyglutamine diseases: Mutant polypeptides and their interactors

Vladimir Vigont, Elena Kaznacheyeva

FEBS Letters, 2013

View PDFchevron_right

Identification of tissue transglutaminase-reactive lysine residues in glyceraldehyde-3-phosphate dehydrogenase

Simona Francese

2002

View PDFchevron_right

Polyglutamine toxicity in non-neuronal cells

Shihua Li

Cell Research, 2010

View PDFchevron_right

A network of protein interactions determines polyglutamine toxicity

M. Duennwald

Proceedings of The National Academy of Sciences, 2006

View PDFchevron_right

Identifying polyglutamine protein species in situ that best predict neurodegeneration

Michelle Gray

Nature Chemical Biology, 2011

View PDFchevron_right

Pathogenic and Non-pathogenic Polyglutamine Tracts Have Similar Structural Properties: Towards a Length-dependent Toxicity Gradient

Jean-louis Mandel

Journal of Molecular Biology, 2007

View PDFchevron_right

Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats: Transglutaminase and poly glutamine protein solubility

Thung Lai

Journal of Neurochemistry, 2004

View PDFchevron_right

Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases

Fabio Sambataro

Progress in Neurobiology, 2012

View PDFchevron_right

Extended Polyglutamine Tracts Cause Aggregation and Structural Perturbation of an Adjacent beta Barrel Protein

Lila Gierasch

Journal of Biological Chemistry, 2006

View PDFchevron_right

Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and -ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length

Arthur Cooper

Proceedings of the National Academy of Sciences, 1997

View PDFchevron_right